CClinicalTrials.gg
CompletedNCT02342873Updated Jul 17, 2017

Nerve Stimulator Versus Ultrasound-guided Interscalene Block for Shoulder Surgery

An interventional study of NS-guided interscalene block and US-guided interscalene block in Pain, sponsored by Cheju Halla General Hospital. Completed at 1 site in Korea, Republic of. Open to participants aged 18 Years to 80 Years. Per ClinicalTrials.gov, last updated 2017-07-17.

Sponsored by Cheju Halla General Hospital · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
53
Allocation
Randomized
Ages
18 Years to 80 Years
Sex
All
01

Study summary

The investigators compared the postoperative analgesia of nerve stimulator-guided and ultrasound-guided interscalene block after shoulder surgery.

Read the detailed description

Ultrasound (US)-guided peripheral nerve block has increased in popularity. It has many advantages such as improved success rate, faster onset time, fewer needle passes, shorter performance time, and reduced procedural pain and vascular puncture. However, there is no information about postoperative analgesia.

Therefore, the investigators tested whether nerve stimulator (NS) - guided interscalene block was inferior to ultrasound-guided block in terms of duration of postoperative analgesia for shoulder surgery.

02

Conditions studied

  • Pain

Keywords

  • ultrasound
  • nerve stimulator
03

In context

Lead sponsor

Cheju Halla General Hospital is the lead sponsor of 7 studies on the registry; none are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 80 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • American Society of Anesthesiologists physical class I - III patients scheduled to undergo shoulder surgery

Exclusion criteria

Exclusion Criteria:

  • coagulopathy, severe pulmonary disease, neuropathy, contralateral diaphragmatic paresis, allergy to study medications
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Quadruple (Participant, Care provider, Investigator, Outcomes assessor)
Enrollment
53 participants (actual)

Study arms

  • Active comparator
    NS-guided interscalene block

    NS-guided interscalene block is performed using 20 ml of 0.75% ropivacaine.

    Procedure: NS-guided interscalene block

  • Experimental
    US-guided interscalene block

    US-guided interscalene block is performed using 20 ml of 0.75% ropivacaine.

    Procedure: US-guided interscalene block

Interventions

  • ProcedureNS-guided interscalene block

    Patients received a standard single injection interscalene block using the modified lateral approach of Borgeat. The interscalene brachial plexus was identified using an insulated needle connected to a nerve stimulator. An insulated needle attached to a nerve stimulator was used to identify the brachial plexus. Placement of the needle was considered adequate if the deltoid, triceps, pectoralis, or biceps muscle motor response was still present at 0.2 - 0.5mA. Ropivacine 0.75% 20ml was used.

  • ProcedureUS-guided interscalene block

    Interscalene block is performed under ultrasound guidance. Linear probe is placed on the ipsilateral interscalene groove visualizing the brachial plexus located between anterior and middle scalene muscles. Using in-plane technique, an insulated needle is advanced into the brachial plexus sheath, into which 20 ml of 0.75% ropivacaine is injected

06

What researchers measure

Primary outcomes

  1. duration of postoperative analgesia

    time from completion of local anesthetic injection until the first request for an analgesic

    Time frame: at 24h after surgery

Secondary outcomes

  1. onset time (complete block of sensory and motor nerve)

    complete block of sensory and motor nerve

    Time frame: until 30min after completion of local anesthetic

  2. patient discomfort (pain score (0 -10) during the procedure)

    pain score (0 -10) during the procedure

    Time frame: at 30 min after block placement

  3. block performance time (the time between the block needle insertion and needle withdrawal)

    the time between the block needle insertion and needle withdrawal.

    Time frame: at 30 min after block placement

  4. The number of needle redirections

    either forward or backward movement of needle at least 1 cm or more

    Time frame: at 30 min after block placement

  5. paresthesia (presence of paresthesia during the procedure)

    presence of paresthesia during the procedure

    Time frame: at 30 min after block placement

  6. motor block of hand

    degree of motor block in the operated hand

    Time frame: at 30 min after block placement

  7. paresthesia of hand

    presence of paresthesia in the operated hand

    Time frame: at 30 min after block placement

  8. Supplemental analgesia

    Time frame: at 24h after surgery

  9. Pain score

    numerical rating scale (0 - 10)

    Time frame: at 24h after surgery

  10. Patient satisfaction

    Patient satisfaction was evaluated using a two-point score: 1, satisfactory (if necessary, I would have the same anesthetic technique); and 2, unsatisfactory (different anesthetic technique).

    Time frame: at 24h after surgery

07

Study locations

1 site
  • Cheju Halla General Hopsital
    Jeju-si, Jeju special governing province 670-744, Korea, Republic of
08

References and documents

Publications

  • Choi S, McCartney CJ. Evidence Base for the Use of Ultrasound for Upper Extremity Blocks: 2014 Update. Reg Anesth Pain Med. 2016 Mar-Apr;41(2):242-50. doi: 10.1097/AAP.0000000000000155. PubMed 25376973 ↗
  • Koscielniak-Nielsen ZJ. Ultrasound-guided peripheral nerve blocks: what are the benefits? Acta Anaesthesiol Scand. 2008 Jul;52(6):727-37. doi: 10.1111/j.1399-6576.2008.01666.x. Epub 2008 May 12. PubMed 18477070 ↗

Individual participant data

Plan to share: Yes

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jul 17, 2017, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT02342873
Lead sponsor
Cheju Halla General Hospital
Responsible party
Chunwoo Yang (staff anesthesiologist, Cheju Halla General Hospital) — Principal investigator
First posted
Jan 21, 2015
Start date
Mar 2014
Primary completion
Feb 2015
Completion
Feb 2015
Last update
Jul 17, 2017

Study contacts

Chunwoo Yang, MD
principal investigator · Dep. of anesthesia and pain medicine, Cheju Halla General Hospital

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jul 2017. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion